Label Revisions Ordered for Utemerin and More Drugs, 1st Update for Zolgensma

March 31, 2021
The Ministry of Health, Labor and Welfare (MHLW) on March 30 ordered label revisions to add new side effect risks for a batch of drugs, including ritodrine (brand name: Utemerin) and magnesium sulfate hydrate as well as for onasemnogene abeparvovec...read more